Status:
COMPLETED
Analysis of Tissues From Patients in Trial of Myo-Inositol to Prevent Lung Cancer
Lead Sponsor:
National Cancer Institute (NCI)
Conditions:
AKT
Eligibility:
All Genders
40-74 years
Phase:
PHASE1
Brief Summary
This study will examine tissue specimens from patients participating in a trial of high-dose myo-inositol to prevent lung cancer. The trial, conducted at the British Columbia Cancer Agency-Vancouver C...
Detailed Description
Human transbronchial biopsy specimens collected under protocol study numbers CDR0000302633; BCCA-U98-0411; BCCA-C02-0298 will be immunohistochemically stained for activated Akt using phospho-specific ...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA:
- Any patients entered into phase 1 myo-inositol trial are eligible for inclusion, provided that they have consented to tissue analysis in the original consent form.
- EXCLUSION CRITERIA:
- None anticipated at this time.
Exclusion
Key Trial Info
Start Date :
April 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00342836
Start Date
April 1 2005
Last Update
March 23 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
British Columbia Cancer Agency (BCCA)
Vancouver, Canada